A nursing student asks the nurse why more is not known about the teratogenic effects of maternal medication ingestion during pregnancy. Which response by the nurse is correct?
“Clinical trials to assess this risk would put the fetus at risk.”
“The relatively new FDA study will allow testing of medications during pregnancy in the future.”
“Most women are reluctant to admit taking medications while they are pregnant.”
“It is safer to recommend that pregnant women avoid medications while pregnant.”
The Correct Answer is A
Choice A Reason:
Clinical trials to assess the teratogenic effects of medications during pregnancy are ethically challenging because they would involve exposing pregnant women and their fetuses to potential risks. The primary concern is the safety of the fetus, as many drugs can cross the placenta and potentially cause harm. Therefore, most of the data on teratogenic effects come from observational studies, case reports, and animal studies rather than controlled clinical trials.
Choice B Reason:
While the FDA has initiatives to improve the safety of medications during pregnancy, it is not accurate to say that a new study will allow testing of medications during pregnancy in the future. The ethical concerns surrounding the exposure of pregnant women to potential teratogens remain a significant barrier. Current efforts focus on improving post-marketing surveillance and encouraging the reporting of adverse effects to gather more data.
Choice C Reason:
Although some women may be reluctant to admit taking medications during pregnancy, this is not the primary reason for the lack of data on teratogenic effects. The main issue is the ethical and practical challenges of conducting clinical trials in pregnant women. Reluctance to report medication use can contribute to underreporting, but it is not the central factor.
Choice D Reason:
Recommending that pregnant women avoid medications is a general precaution, but it does not address the reason why more is not known about teratogenic effects. The avoidance of medications is advised to minimize potential risks, but the lack of data is primarily due to the ethical constraints of conducting clinical trials in this population.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A: Excretion
Excretion is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine), but also via bile, sweat, saliva, and other routes. While excretion is a crucial phase of pharmacokinetics, it is not directly impacted by the first pass effect. The first pass effect primarily involves the metabolism of a drug before it reaches systemic circulation, which occurs prior to the excretion phase.
Choice B: Metabolism
The first pass effect, also known as first-pass metabolism or presystemic metabolism, significantly impacts the metabolism phase of pharmacokinetics. This phenomenon occurs when a drug is metabolized at a specific location in the body, such as the liver or gut wall, before it reaches systemic circulation. As a result, the concentration of the active drug is reduced, affecting its bioavailability. The liver is the primary site for this metabolic process, where enzymes break down the drug, potentially leading to a significant reduction in its therapeutic effect.
Choice C: Distribution
Distribution refers to the process by which a drug is transported from the bloodstream to various tissues and organs in the body. This phase is influenced by factors such as blood flow, tissue permeability, and binding to plasma proteins. However, the first pass effect does not directly alter the distribution phase. Instead, it affects the amount of drug that enters systemic circulation, which in turn can influence the extent of distribution.
Choice D: Absorption
Absorption is the process by which a drug enters the bloodstream from its site of administration. This phase is crucial for determining the onset of a drug’s action. While the first pass effect occurs after absorption, it does not directly change the absorption phase itself. Instead, it affects the drug’s concentration after it has been absorbed and before it reaches systemic circulation.
Correct Answer is B
Explanation
Choice A Reason:
Oxygenation of the cells is a necessary process during reperfusion, but it is not the direct cause of reperfusion injury. The injury occurs due to the sudden influx of oxygen, which leads to the formation of reactive oxygen species (ROS) or free radicals. These free radicals cause oxidative stress and damage to the myocardial cells.
Choice B Reason:
Free radical formation is the primary mechanism behind reperfusion injury. When blood flow is restored to the ischemic myocardium, the sudden reintroduction of oxygen leads to the production of free radicals. These free radicals cause significant oxidative damage to the cell membranes, proteins, and DNA, exacerbating the injury to the heart tissue.
Choice C Reason:
An increased metabolic state can occur during reperfusion as the cells attempt to recover from ischemia. However, it is not the direct cause of reperfusion injury. The primary issue is the oxidative stress caused by free radicals, not the metabolic changes themselves.
Choice D Reason:
Lactic acid build-up is a consequence of anaerobic metabolism during the ischemic period, not a cause of reperfusion injury. During ischemia, cells switch to anaerobic metabolism, leading to lactic acid accumulation. However, once oxygen is reintroduced, the focus shifts to the oxidative damage caused by free radicals rather than lactic acid.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today